Johansen PB - Search Results

1

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H. Johansen PB, et al. Growth Horm IGF Res. 1999 Apr;9(2):106-13. doi: 10.1054/ghir.1999.9998. Growth Horm IGF Res. 1999. PMID: 10373343

2

Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.

Johansen PB, Hansen KT, Andersen JV, Johansen NL. Johansen PB, et al. Among authors: johansen nl. Xenobiotica. 1998 Nov;28(11):1083-92. doi: 10.1080/004982598238976. Xenobiotica. 1998. PMID: 9879640

3

Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in rats.

Johansen PB, Rasmussen SN, Ostergaard PB. Johansen PB, et al. Thromb Res. 1994 Aug 15;75(4):453-64. doi: 10.1016/0049-3848(94)90260-7. Thromb Res. 1994. PMID: 7997983

4

Pharmacological characterization of a biosynthetic trisulfide-containing hydrophobic derivative of human growth hormone: comparison with standard 22 K growth hormone.

Thomsen MK, Hansen BS, Nilsson P, Nowak J, Johansen PB, Thomsen PD, Christiansen J. Thomsen MK, et al. Among authors: johansen pb. Pharmacol Toxicol. 1994 Jun;74(6):351-8. doi: 10.1111/j.1600-0773.1994.tb01372.x. Pharmacol Toxicol. 1994. PMID: 7937569

5

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.

Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C, Johansen PB, Rossetti L, Jelicks LA, Serup P, Nishimura E, Charron MJ. Gelling RW, et al. Among authors: johansen pb. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1438-43. doi: 10.1073/pnas.0237106100. Epub 2003 Jan 24. Proc Natl Acad Sci U S A. 2003. PMID: 12552113 Free PMC article.

6

Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs.

Malmlöf K, Bauer MK, Johansen PB, Ankersen M, Veldhuis JD. Malmlöf K, et al. Among authors: johansen pb. Endocrine. 2001 Dec;16(3):195-9. doi: 10.1385/ENDO:16:3:195. Endocrine. 2001. PMID: 11954663

7

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats.

Andersen NB, Malmlöf K, Johansen PB, Andreassen TT, Ørtoft G, Oxlund H. Andersen NB, et al. Among authors: johansen pb. Growth Horm IGF Res. 2001 Oct;11(5):266-72. doi: 10.1054/ghir.2001.0239. Growth Horm IGF Res. 2001. PMID: 11735244

8

Comparison of methods of analysis of body composition in hypophysectomized rats treated with rat growth hormone.

Johansen PB, Flyvbjerg A, Wilken M, Malmlöf K. Johansen PB, et al. Growth Horm IGF Res. 2000 Dec;10(6):342-8. doi: 10.1054/ghir.2000.0173. Growth Horm IGF Res. 2000. PMID: 11161965

9

Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats.

Malmlöf K, Johansen PB, Haahr PM, Wilken M, Oxlund H. Malmlöf K, et al. Among authors: johansen pb. Growth Horm IGF Res. 1999 Dec;9(6):445-50. doi: 10.1054/ghir.1999.0128. Growth Horm IGF Res. 1999. PMID: 10629165

10

Pharmacological characterisation of a new oral GH secretagogue, NN703.

Hansen BS, Raun K, Nielsen KK, Johansen PB, Hansen TK, Peschke B, Lau J, Andersen PH, Ankersen M. Hansen BS, et al. Among authors: johansen pb. Eur J Endocrinol. 1999 Aug;141(2):180-9. doi: 10.1530/eje.0.1410180. Eur J Endocrinol. 1999. PMID: 10427162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results